CRAIG RICK TRAVIS, MD
Osteopathic Medicine at 87 St, Miami, FL
License number
Florida ME0061165
Category
Osteopathic Medicine
Type
Emergency Medicine
Address
Address
5901 SW 87Th St, Miami, FL 33143
Phone
(305) 668-9877
Personal information
See more information about CRAIG RICK TRAVIS at radaris.comName
Address
Phone
5901 SW 87Th St, Miami, FL 33143
250 NW 40Th Ave, Delray Beach, FL 33445
5901 87Th St, South Miami, FL 33143
Gainesville, FL
Miami, FL
Professional information
President At Immugen Pharmaceuticals, Inc.
Position:
Founder at Immugen Pharmaceuticals, Inc., Managing Director at Beachcliff Resorts, Inc.
Location:
Miami/Fort Lauderdale Area
Industry:
Biotechnology
Work:
Immugen Pharmaceuticals, Inc.
-
Founder
Beachcliff Resorts, Inc.
since 1998
-
Managing Director
Immugen Pharmaceuticals, Inc.
May 1999 - May 2012
-
President
Education:
Chicago Medical School at Rosalind Franklin U-Med & Science 1972 - 1976
MD, Medicine
MD, Medicine
Skills:
Healthcare, Biotechnology, Entrepreneurship, Lifesciences, Clinical Research, Hospitals, Emergency Medicine
Interests:
Cannabinoid research, particularly with non-psychoactive compounds which can modify the immune response.
Dr. Craig R Travis, South Miami FL - MD (Doctor of Medicine)
Specialties:
Emergency Medicine
Address:
5901 SW 87Th St, South Miami 33143
(305) 668-9877 (Phone)
(305) 668-9877 (Phone)
Certifications:
Emergency Medicine, 2006
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Rosalind Franklin University of Medicine and Science / Chicago Medical School
Rosalind Franklin University of Medicine and Science / Chicago Medical School
Alkylated Resorcinol Derivatives For The Treatment Of Immune Diseases
US Patent:
6274635, Aug 14, 2001
Filed:
Mar 22, 2000
Appl. No.:
9/533386
Inventors:
Craig A. Travis - South Miami FL
Assignee:
Immugen Pharmaceuticals Inc. - Miami FL
International Classification:
C07C 3912, C07C 3900, C07C 4100, A01N 3100, A01N 4316
US Classification:
514885
Abstract:
The present invention provides a method, compounds, and compositions for treating a disease associated with immune dysfunction. In accordance with the method, a pharmacologically-acceptable composition including at least one compound selected from the group of compounds consisting of 5-alkyl-resorcinol derivatives, cannabinol derivatives, cannabidiol derivatives, cannabigerol derivatives, and combinations thereof is administered to a patient under conditions sufficient to attenuate the dysfunction within the immune system. The invention also provides an antiviral cannabinol derivative that can be used in the inventive method. The invention also provides an alkylated resorcinol derivative and a method of using the alkylated resorcinol derivative to attenuate the growth of a neoplasm. The method and compound are useful for treating diseases of the immune system, such as HIV disease and neoplastic disorders.
Methods And Compounds For Inhibiting Eicosanoid Metabolism And Platelet Aggregation
US Patent:
2002013, Sep 26, 2002
Filed:
Sep 28, 2001
Appl. No.:
09/967353
Inventors:
Craig Travis - South Miami FL, US
International Classification:
A61K031/05
US Classification:
514/731000, 435/002000
Abstract:
The invention provides a method for attenuating the aggregation and/or activation of blood platelets within a blood product. In accordance with this method, a cannabinoid or resorcinolic compound is introduced into the blood product under conditions sufficient to inhibit the aggregation and/or activation of blood platelets within the blood product. The invention also pertains to the use of a cannabinoid or resorcinolic compound to prepare a composition suitable for inhibiting the activation and/or aggregation of blood platelets and to such compositions. The invention also pertains to a method of selectively inhibiting COX-1 and thromboxane synthase within a cell or blood platelet.
Topical Formulations Of Resorcinols And Cannibinoids And Methods Of Use
US Patent:
2003023, Dec 18, 2003
Filed:
Mar 18, 2003
Appl. No.:
10/391845
Inventors:
Craig Travis - South Miami FL, US
Assignee:
Immugen Pharmaceuticals, Inc. - South Miami FL
International Classification:
A61K031/353, A61K035/78
US Classification:
424/776000, 514/455000, 514/454000
Abstract:
In one aspect, the invention provides a method for preventing the transmission of HIV from one individual to another. In accordance with the method, a pharmacologically-acceptable composition including at least one resorcinol derivative compound and/or cannabinoid (e.g., cannabinol derivatives, 8-THC derivatives, cannabichromene derivatives, cannabidiol derivatives, cannabigerol derivatives) (including combinations thereof) is administered topically to a first individual harboring HIV, or to a second individual at risk of infection with HIV, proximate in time with contact between the first individual and the second individual. The invention also provides topical formulations of at least one resorcinol and/or cannabinoid and water insoluble polymers as hydrogels.
Antiviral Methods And Compounds
US Patent:
2003017, Sep 11, 2003
Filed:
Jan 16, 2003
Appl. No.:
10/345714
Inventors:
Craig Travis - South Miami FL, US
Assignee:
Immugen Pharmaceuticals, Inc. - South Miami FL
International Classification:
A61K031/5377, A61K031/382, A61K031/353
US Classification:
514/233500, 514/312000, 514/432000, 514/456000, 544/145000, 544/151000, 546/153000, 549/023000, 549/399000
Abstract:
The invention provides a method, compounds, and compositions for inhibiting the replication or proliferation of a virus. In accordance with the invention, at least one cannabichromene derivative is exposed to the virus, a host cell, or an infected cell under conditions sufficient to inhibit the replication or proliferation of the virus.
Method For Treatment Of Hiv And Diseases Of Immune Dysregulation
US Patent:
8586767, Nov 19, 2013
Filed:
Jan 23, 2012
Appl. No.:
13/355676
Inventors:
Craig Rick Travis - South Miami FL, US
International Classification:
C07D 311/80, A01N 43/16
US Classification:
549390, 514454
Abstract:
This invention discloses cannabinoid derivatives and pharmaceutical uses thereof.
Treatment Of Immune Dysregulation Using Cannabinoid Derivatives
US Patent:
2014006, Mar 6, 2014
Filed:
Aug 27, 2013
Appl. No.:
14/010729
Inventors:
Craig TRAVIS - Miami FL, US
International Classification:
A61K 31/352
US Classification:
514454, 514453
Abstract:
This invention discloses cannabinoid derivatives and pharmaceutical uses thereof.
Treatment Of Immune Dysregulation Using Cannabinoid Derivatives
US Patent:
2012028, Nov 15, 2012
Filed:
Jul 23, 2012
Appl. No.:
13/555195
Inventors:
Craig Rick Travis - South Miami FL, US
International Classification:
A61K 31/352, A61P 31/18, A61P 31/14, A61K 31/35
US Classification:
514454, 514453
Abstract:
This invention discloses cannabinoid derivatives and pharmaceutical uses thereof.
Treatment Of Hiv And Diseases Of Immune Dysregulation
US Patent:
2008010, May 8, 2008
Filed:
Oct 29, 2007
Appl. No.:
11/978318
Inventors:
Craig Travis - South Miami FL, US
International Classification:
A61K 31/352, A61P 19/00, A61P 29/00, A61P 31/00, A61P 31/18, A61P 5/00, A61P 9/00, C07C 39/17, A61K 31/05, C07D 221/12, A61K 31/435, C07D 311/80
US Classification:
514298000, 568733000, 514732000, 546109000, 549390000, 514454000, 549391000
Abstract:
This invention discloses cannabinoid derivatives and pharmaceutical uses thereof including the treatment of HIV and diseases of immune dysregulation.